Met Life Investment Management, LLC Tyra Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 12,207 shares of TYRA stock, worth $148,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,207
Previous 12,207
-0.0%
Holding current value
$148,315
Previous $195,000
46.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TYRA
# of Institutions
105Shares Held
47.2MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$127 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$78.3 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$56.6 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$50.8 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$49.6 Million89.47% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $510M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...